Hinrich Wieder

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

Florian Lordick, Katja Ott, Bernd‐Joachim Krause et al. · The Lancet Oncology · 2007 · 808 citations

Medicine, Oncology, Gastroenterology +10

Metabolic Imaging Predicts Response, Survival, and Recurrence in Adenocarcinomas of the Esophagogastric Junction

Katja Ott, Wolfgang Weber, Florian Lordick et al. · Journal of Clinical Oncology · 2006 · 464 citations

Medicine, Nuclear Medicine, Oncology +17

Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment

Hinrich Wieder, Björn L.D.M. Brücher, Frank Zimmermann et al. · Journal of Clinical Oncology · 2004 · 460 citations · Full text

Medicine, Oncology, Surgery +17

Early Response Assessment Using 3′-Deoxy-3′-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma

Ken Herrmann, Hinrich Wieder, Andreas K. Buck et al. · Clinical Cancer Research · 2007 · 154 citations

Medicine, Nuclear Medicine, Oncology +12

Early Metabolic Response Evaluation by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Allows <i>In vivo</i> Testing of Chemosensitivity in Gastric Cancer: Long-term Results of a Prospective Study

Katja Ott, Ken Herrmann, Florian Lordick et al. · Clinical Cancer Research · 2008 · 137 citations

Medicine, Nuclear Medicine, Oncology +15